Details for: PPP1R2
Gene ID: 5504
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: PPP1R2
Ensembl ID: ENSG00000184203
Description: protein phosphatase 1 regulatory inhibitor subunit 2
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 52.09rCSI 35.09%PRS 40.38
-
CSI 36.37rCSI 62.22%PRS 53.54
-
CSI 32.19rCSI 64.17%PRS 49.82
-
CSI 28.67rCSI 21.69%PRS 43.18
-
CSI 27.18rCSI 21.39%PRS 38.11
-
CSI 25.53rCSI 32.04%PRS 40.79
-
CSI 23.8rCSI 22.88%PRS 56.65
-
CSI 22.65rCSI 22.61%PRS 27.79
-
CSI 19.52rCSI 35.24%PRS 61.44
-
CSI 18.87rCSI 26.68%PRS 42.3
-
CSI 17.36rCSI 34.41%PRS 61.14
-
CSI 16.94rCSI 17.27%PRS 44.21
-
CSI 16.01rCSI 20.12%PRS 76.97
-
CSI 15.63rCSI 52.84%PRS 44.01
-
CSI 15.21rCSI 43.42%PRS 47.96
-
CSI 13.25rCSI 9.84%PRS 44.58
-
CSI 13.23rCSI 14.17%PRS 30.25
-
CSI 12.84rCSI 10.2%PRS 52.84
-
CSI 9.89rCSI 16.6%PRS 20.43
-
CSI 9.75rCSI 9.01%PRS 52.22
-
CSI 9.57rCSI 8.32%PRS 40.07
-
CSI 9.1rCSI 21.69%PRS 35.41
-
CSI 8.78rCSI 13.87%PRS 32.95
-
CSI 8.41rCSI 5.9%PRS 58.81
-
CSI 8.12rCSI 26.57%PRS 66.65
-
CSI 7.81rCSI 13.35%PRS 58.22
-
CSI 7.81rCSI 14.9%PRS 48.09
-
CSI 6.89rCSI 6.04%PRS 41.35
-
CSI 6.74rCSI 5.93%PRS 23.99
-
CSI 6.71rCSI 14.78%PRS 36.07
-
CSI 6.6rCSI 4.94%PRS 46.34
-
CSI 6.41rCSI 15.21%PRS 38.1
-
CSI 6.33rCSI 16.7%PRS 38.15
-
CSI 6.23rCSI 15.82%PRS 30.61
-
CSI 6.23rCSI 15.41%PRS 30.61
-
CSI 6.21rCSI 13.93%PRS 20.99
-
CSI 6.01rCSI 5.79%PRS 33.22
-
CSI 5.93rCSI 11.23%PRS 68.49
-
CSI 5.71rCSI 8.77%PRS 38.07
-
CSI 5.67rCSI 6.87%PRS 33.69
-
CSI 5.48rCSI 8.78%PRS 63.79
-
CSI 5.4rCSI 9.25%PRS 41.34
-
CSI 5.36rCSI 12.38%PRS 26.7
-
CSI 5.33rCSI 6.25%PRS 45.08
-
CSI 5.24rCSI 6.08%PRS 60.86
-
CSI 5.22rCSI 3.64%PRS 33.94
-
CSI 5.17rCSI 16.55%PRS 29.27
-
CSI 5.14rCSI 7.84%PRS 30.04
-
CSI 5.12rCSI 6.34%PRS 28.89
-
CSI 5.06rCSI 3.93%PRS 31.93
-
CSI 5.05rCSI 3.79%PRS 67.75
-
CSI 4.95rCSI 12.91%PRS 42.96
-
CSI 4.65rCSI 6.38%PRS 53.37
-
CSI 4.55rCSI 4.24%PRS 32.33
-
CSI 4.41rCSI 9.66%PRS 41.57
-
CSI 4.27rCSI 5.6%PRS 74.64
-
CSI 3.98rCSI 5.43%PRS 27.92
-
CSI 3.95rCSI 8.87%PRS 54.08
-
CSI 3.83rCSI 3.76%PRS 64.27
-
CSI 3.68rCSI 9.32%PRS 25.23
-
CSI 3.63rCSI 4.85%PRS 69.01
-
CSI 3.59rCSI 11.57%PRS 32.96
-
CSI 3.54rCSI 4.82%PRS 61.23
-
CSI 3.53rCSI 7.33%PRS 31.53
-
CSI 3.45rCSI 5.6%PRS 31.76
-
CSI 3.45rCSI 13.42%PRS 50.75
-
CSI 3.36rCSI 3.78%PRS 47.59
-
CSI 3.35rCSI 3.29%PRS 46.5
-
CSI 3.32rCSI 3.36%PRS 79.33
-
CSI 3.25rCSI 2.63%PRS 43.96
-
CSI 3.23rCSI 2.77%PRS 43.53
-
CSI 3.21rCSI 6.25%PRS 33.57
-
CSI 3.17rCSI 15.2%PRS 30.06
-
CSI 3.16rCSI 36.74%PRS 74.53
-
CSI 3.16rCSI 3.12%PRS 72.5
-
CSI 3.13rCSI 4.82%PRS 38.29
-
CSI 3.04rCSI 2.28%PRS 34.77
-
CSI 3.03rCSI 3.17%PRS 34.3
-
CSI 2.92rCSI 3.74%PRS 71.37
-
CSI 2.89rCSI 8.34%PRS 51.27
-
CSI 2.87rCSI 2.42%PRS 48.06
-
CSI 2.85rCSI 6.51%PRS 27.81
-
CSI 2.82rCSI 1.96%PRS 43.74
-
CSI 2.78rCSI 2.23%PRS 52.66
-
CSI 2.76rCSI 3.56%PRS 21.12
-
CSI 2.76rCSI 3.82%PRS 39.46
-
CSI 2.74rCSI 4.81%PRS 26.07
-
CSI 2.67rCSI 3.66%PRS 36.18
-
CSI 2.67rCSI 3.97%PRS 35.78
-
CSI 2.67rCSI 3.25%PRS 39.13
-
CSI 2.64rCSI 2.14%PRS 33.26
-
CSI 2.6rCSI 3.81%PRS 34.21
-
CSI 2.6rCSI 3.11%PRS 50.78
-
CSI 2.54rCSI 2.23%PRS 36.79
-
CSI 2.5rCSI 5.72%PRS 31.86
-
CSI 2.49rCSI 1.84%PRS 27.82
-
CSI 2.45rCSI 2.56%PRS 32.95
-
CSI 2.45rCSI 2.56%PRS 66.61
-
CSI 2.41rCSI 2.97%PRS 63.09
-
CSI 2.4rCSI 1.99%PRS 32.94
-
CSI 0.1rCSI 3.5%PRS 63.7%
-
CSI 0.2rCSI 3.3%PRS 58.3%
-
CSI 0.2rCSI 4.6%PRS 62.4%
-
CSI 0.3rCSI 1.4%PRS 68.8%
-
CSI 0.3rCSI 3.0%PRS 53.7%
-
CSI 0.3rCSI 2.5%PRS 51.9%
-
CSI 0.3rCSI 1.7%PRS 55.6%
-
CSI 0.4rCSI 4.6%PRS 68.5%
-
CSI 0.4rCSI 8.3%PRS 54.9%
-
CSI 0.4rCSI 1.8%PRS 42.4%
-
CSI 0.4rCSI 0.8%PRS 53.3%
-
CSI 0.4rCSI 2.5%PRS 53.1%
-
CSI 0.4rCSI 0.7%PRS 56.7%
-
CSI 0.4rCSI 2.2%PRS 44.5%
-
CSI 0.4rCSI 2.1%PRS 43.8%
-
CSI 0.4rCSI 0.6%PRS 47.9%
-
CSI 0.4rCSI 2.7%PRS 65.2%
-
CSI 0.4rCSI 1.8%PRS 48.9%
-
CSI 0.4rCSI 0.9%PRS 23.6%
-
CSI 0.4rCSI 3.2%PRS 52.7%
-
CSI 0.5rCSI 2.9%PRS 26.6%
-
CSI 0.5rCSI 0.9%PRS 40.8%
-
CSI 0.5rCSI 2.6%PRS 72.3%
-
CSI 0.5rCSI 2.9%PRS 21.5%
-
CSI 0.5rCSI 2.3%PRS 55.8%
-
CSI 0.5rCSI 2.0%PRS 55.6%
-
CSI 0.5rCSI 1.5%PRS 35.2%
-
CSI 0.5rCSI 1.4%PRS 48.3%
-
CSI 0.5rCSI 2.8%PRS 58.2%
-
CSI 0.5rCSI 0.8%PRS 25.3%
-
CSI 0.6rCSI 1.5%PRS 46.8%
-
CSI 0.6rCSI 2.3%PRS 48.6%
-
CSI 0.6rCSI 2.5%PRS 50.2%
-
CSI 0.6rCSI 3.6%PRS 70.9%
-
CSI 0.6rCSI 14.2%PRS 65.2%
-
CSI 0.6rCSI 3.6%PRS 59.0%
-
CSI 0.6rCSI 3.2%PRS 48.4%
-
CSI 0.6rCSI 14.6%PRS 19.7%
-
CSI 0.6rCSI 3.4%PRS 68.3%
-
CSI 0.6rCSI 2.0%PRS 41.2%
-
CSI 0.6rCSI 4.7%PRS 22.5%
-
CSI 0.6rCSI 3.8%PRS 44.0%
-
CSI 0.7rCSI 3.1%PRS 61.4%
-
CSI 0.7rCSI 1.3%PRS 62.4%
-
CSI 0.7rCSI 1.6%PRS 48.1%
-
CSI 0.7rCSI 2.5%PRS 70.9%
-
CSI 0.7rCSI 0.6%PRS 29.7%
-
CSI 0.7rCSI 3.2%PRS 71.9%
-
CSI 0.7rCSI 2.5%PRS 71.6%
-
CSI 0.7rCSI 1.3%PRS 19.8%
-
CSI 0.7rCSI 2.1%PRS 25.9%
-
CSI 0.8rCSI 2.1%PRS 40.8%
-
CSI 0.8rCSI 1.0%PRS 36.9%
-
CSI 0.8rCSI 1.2%PRS 36.5%
-
CSI 0.8rCSI 1.1%PRS 25.7%
-
CSI 0.8rCSI 2.8%PRS 19.4%
-
CSI 0.8rCSI 1.5%PRS 24.5%
-
CSI 0.8rCSI 0.9%PRS 30.2%
-
CSI 0.8rCSI 3.9%PRS 57.7%
-
CSI 0.8rCSI 2.0%PRS 44.5%
-
CSI 0.9rCSI 1.6%PRS 47.2%
-
CSI 0.9rCSI 1.9%PRS 46.1%
-
CSI 0.9rCSI 0.9%PRS 37.5%
-
CSI 0.9rCSI 4.0%PRS 31.2%
-
CSI 0.9rCSI 1.5%PRS 30.7%
-
CSI 1.0rCSI 2.8%PRS 57.8%
-
CSI 1.0rCSI 2.7%PRS 54.2%
-
CSI 1.0rCSI 1.1%PRS 20.3%
-
CSI 1.0rCSI 1.5%PRS 41.2%
-
CSI 1.0rCSI 2.2%PRS 32.0%
-
CSI 1.0rCSI 2.5%PRS 65.3%
-
CSI 1.0rCSI 0.7%PRS 49.9%
-
CSI 1.0rCSI 1.4%PRS 41.6%
-
CSI 1.0rCSI 2.0%PRS 32.8%
-
CSI 1.0rCSI 2.1%PRS 55.7%
-
CSI 1.0rCSI 23.5%PRS 90.3%
-
CSI 1.0rCSI 1.5%PRS 34.5%
-
CSI 1.0rCSI 0.9%PRS 35.7%
-
CSI 1.1rCSI 2.9%PRS 36.0%
-
CSI 1.1rCSI 0.9%PRS 32.5%
-
CSI 1.1rCSI 3.3%PRS 21.4%
-
CSI 1.1rCSI 26.1%PRS 20.5%
-
CSI 1.1rCSI 3.5%PRS 23.1%
-
CSI 1.1rCSI 3.9%PRS 49.1%
-
CSI 1.1rCSI 2.0%PRS 30.6%
-
CSI 1.1rCSI 1.5%PRS 35.8%
-
CSI 1.2rCSI 1.6%PRS 30.2%
-
CSI 1.2rCSI 6.2%PRS 48.9%
-
CSI 1.2rCSI 1.8%PRS 50.2%
-
CSI 1.2rCSI 1.9%PRS 37.2%
-
CSI 1.2rCSI 2.1%PRS 31.5%
-
CSI 1.2rCSI 2.6%PRS 47.2%
-
CSI 1.2rCSI 2.5%PRS 41.9%
-
CSI 1.2rCSI 1.4%PRS 31.2%
-
CSI 1.2rCSI 4.6%PRS 28.8%
-
CSI 1.2rCSI 3.2%PRS 55.3%
-
CSI 1.2rCSI 4.0%PRS 36.6%
-
CSI 1.2rCSI 4.7%PRS 21.2%
-
CSI 1.2rCSI 1.9%PRS 33.5%
-
CSI 1.3rCSI 2.1%PRS 25.4%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 1966857239
Symbol: IPP2_HUMAN
Name: Protein phosphatase inhibitor 2
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 7949733
Title: Cloning and characterization of human phosphatase inhibitor-2 (IPP-2) sequences.
PubMed ID: 7949733
DOI: 10.1007/bf00369318
PubMed ID: 8119416
Title: Cloning of the complete coding region for human protein phosphatase inhibitor 2 using the two hybrid system and expression of inhibitor 2 in E. coli.
PubMed ID: 8119416
PubMed ID: 9126490
Title: Genetic analysis of human type 1 protein phosphatase inhibitor 2 in insulin-resistant Pima Indians.
PubMed ID: 9126490
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 12665801
Title: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.
PubMed ID: 12665801
DOI: 10.1038/nbt810
PubMed ID: 18220336
Title: Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.
PubMed ID: 18220336
DOI: 10.1021/pr0705441
PubMed ID: 18250156
Title: A novel ATM-dependent pathway regulates protein phosphatase 1 in response to DNA damage.
PubMed ID: 18250156
DOI: 10.1128/mcb.01711-07
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 23506001
Title: Identification and characterization of two distinct PPP1R2 isoforms in human spermatozoa.
PubMed ID: 23506001
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
Sequence Information:
- Length: 205
- Mass: 23015
- Checksum: FFC005B07CD5ABFC
- Sequence:
MAASTASHRP IKGILKNKTS TTSSMVASAE QPRGNVDEEL SKKSQKWDEM NILATYHPAD KDYGLMKIDE PSTPYHSMMG DDEDACSDTE ATEAMAPDIL ARKLAAAEGL EPKYRIQEQE SSGEEDSDLS PEEREKKRQF EMKRKLHYNE GLNIKLARQL ISKDLHDDDE DEEMLETADG ESMNTEESNQ GSTPSDQQQN KLRSS